Inotersen improved quality of life, polyneuropathy and cardiomyopathy in a diverse group of patients with hereditary transthyretin amyloidosis in the phase 3 study NEURO-TTR
Event:
ESC Congress 2018
Topic:
Infiltrative Myocardial Disease
Session:
Cardiomyopathies: various aspects
